HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Jiro Takahashi Selected Research

astaxanthine (astaxanthin)

12/2021The Beneficial Effects of Astaxanthin on Glucose Metabolism and Modified Low-Density Lipoprotein in Healthy Volunteers and Subjects with Prediabetes.
3/2021The effect of aging on the antioxidative activity of astaxanthin in human aqueous humor.
9/2020Effect of Astaxanthin on the Expression and Activity of Aquaporin-3 in Skin in an In-Vitro Study.
7/2019Effects of astaxanthin on VEGF level and antioxidation in human aqueous humor: difference by sex.
7/2013Effects of astaxanthin on antioxidation in human aqueous humor.
9/2012Astaxanthin functions differently as a selective peroxisome proliferator-activated receptor γ modulator in adipocytes and macrophages.
4/2007Effects of astaxanthin in obese mice fed a high-fat diet.
10/2006Effects of astaxanthin supplementation on exercise-induced fatigue in mice.
1/2004Prevention of diabetic nephropathy by treatment with astaxanthin in diabetic db/db mice.
1/2002Astaxanthin protects beta-cells against glucose toxicity in diabetic db/db mice.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Jiro Takahashi Research Topics

Disease

4Cataract (Cataracts)
03/2021 - 07/2008
3Body Weight (Weight, Body)
04/2007 - 01/2004
2Insulin Resistance
12/2021 - 09/2012
2Obesity
09/2012 - 04/2007
2Type 2 Diabetes Mellitus (MODY)
01/2004 - 01/2002
1Bites and Stings (Sting)
12/2021
1Wounds and Injuries (Trauma)
12/2021
1Disseminated Intravascular Coagulation
12/2021
1Hemorrhage
12/2021
1Prediabetic State (Prediabetes)
12/2021
1Diabetes Mellitus
09/2020
1Metabolic Syndrome (Dysmetabolic Syndrome X)
04/2007
1Fatigue
10/2006
1Diabetic Nephropathies (Diabetic Nephropathy)
01/2004

Drug/Important Bio-Agent (IBA)

10astaxanthine (astaxanthin)IBA
12/2021 - 01/2002
1VenomsIBA
12/2021
1Antivenins (Antivenoms)IBA
12/2021
1Prothrombin (Factor II)IBA
12/2021
1LipidsIBA
12/2021
1Glucose (Dextrose)FDA LinkGeneric
12/2021
1LDL Lipoproteins (beta Lipoproteins)IBA
12/2021
1Carotenoids (Carotene)IBA
09/2012
1flavangenolIBA
07/2008
1Blood Glucose (Blood Sugar)IBA
01/2004
1AlbuminsIBA
01/2004
18-Hydroxy-2'-DeoxyguanosineIBA
01/2004

Therapy/Procedure

1Glycemic Control
12/2021